AVID BIOSERVICES INC (CDMO)
US05368M1062 - Common Stock
CDMO Stock Earnings: Avid Bioservices Misses EPS, Beats Revenue for Q3 2024
CDMO stock results show that Avid Bioservices missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
CDMO Stock Earnings: Avid Bioservices Misses EPS, Beats Revenue for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avid Bioservices (NASDAQ:CDMO) just reported results for the third quarter of 2...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- --...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avid Bioservices, Inc. ("Avid" or the "Company") (NASDAQ: CDMO). Such investors...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avid Bioservices, Inc. ("Avid" or the "Company") (NASDAQ: CDMO). Such investors...
Top Buys by Directors: Hancock's $336.8K Bet on CDMO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avid Bioservices, Inc. ("Avid" or the "Company") (NASDAQ: CDMO). Such investors...
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing...
Commit To Purchase Avid Bioservices At $5, Earn 19.8% Annualized Using Options
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO
Why Is MindMed (MNMD) Stock Up 32% Today?
MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!
NVO Stock Alert: Novo Nordisk Pops on New Weight-Loss Drug
Novo Nordisk stock is gaining on Thursday as NVO investors react to positive news from its new weight loss drug clinical trial.
Why Is Avid Bioservices (CDMO) Stock Down 30% Today?
Avid Bioservices stock is falling on Thursday after the company priced CDMO shares in a $160 million private placement for senior notes.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing...
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing...
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing...
Contract research firms gain after Q4 results (NYSE:IQV)
Shares of contract research organizations IQVIA Holdings (IQV) and Charles River Laboratories (CRL) gain as their Q4 results exceed expectations. Read more here.